BriaCell Therapeutics Corp. (BCTX)
NASDAQ: BCTX · Real-Time Price · USD
2.960
-0.150 (-4.82%)
At close: Jun 27, 2025, 4:00 PM
2.950
-0.010 (-0.34%)
After-hours: Jun 27, 2025, 7:20 PM EDT
BriaCell Therapeutics Employees
BriaCell Therapeutics had 16 employees as of July 31, 2023. The number of employees increased by 10 or 166.67% compared to the previous year.
Employees
16
Change
10
Growth
166.67%
Revenue / Employee
n/a
Profits / Employee
-$1,214,666
Market Cap
19.04M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Jul 31, 2023 | 16 | 10 | 166.67% |
| Jul 31, 2021 | 6 | 0 | - |
| Aug 1, 2019 | 6 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 94,300 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
BCTX News
- 4 days ago - BriaCell Announces Positive Recommendation from Data Safety Monitoring Board for Pivotal Phase 3 Study in Metastatic Breast Cancer - GlobeNewsWire
- 24 days ago - BriaCell Announces Virtual Investor Presentations on Thursday, June 12 and Thursday, June 26 - GlobeNewsWire
- 26 days ago - BriaCell Reports Robust Overall Survival and Clinical Benefit Data at ASCO 2025 - GlobeNewsWire
- 4 weeks ago - BriaCell Bria-OTS™ Phase 1/2 Study Clears Safety Evaluation; Doses First Patient in Combination with Checkpoint Inhibitor - GlobeNewsWire
- 5 weeks ago - BriaCell Abstracts Showcase Positive Survival and Clinical Benefit Data at ASCO 2025 - GlobeNewsWire
- 5 weeks ago - BriaCell CEO Letter to Shareholders - GlobeNewsWire
- 2 months ago - BriaCell Reports “Late-Breaker” Phase 3 Data at AACR 2025: Positive Tolerability Profile and Potential Response Biomarkers Identified - GlobeNewsWire
- 2 months ago - BriaCell Therapeutics Announces Closing of $13.8 million Public Offering - GlobeNewsWire